Astrana Health, Inc. vs ATIF Holdings Ltd · ASTH FY2025 (ended 2025-12-31) vs AUC FY2024 (ended 2024-07-31) · computed from SEC XBRL filings
| Metric | ASTH FY2025 · 2025-12-31 | AUC FY2024 · 2024-07-31 518d off — excluded |
|---|---|---|
| Revenue | $3.18B | n.m. |
| Revenue growth (YoY) | 56.4% | n.m. |
| Operating margin | 2.5% | n.m. |
| Net margin | 0.7% | n.m. |
| FCF margin | 3.3% | n.m. |
| Capex % of revenue | 0.3% | n.m. |
Want ASTH against its full peer set, not just AUC?
A CompsDesk subscription covers unlimited packs: up to 12 peers you choose, up to 23 metrics (6 core guaranteed), trends for every filed year (up to five), the subject's figures cited to their SEC tag, form and period with every company identified by its CIK — PDF-ready HTML + CSV, generated on demand.
Each column is that company's OWN annual period, labeled above with its fiscal year and period end. AUC's is the annual period ending closest to ASTH's 2025-12-31: where AUC has already filed a fiscal year ASTH has not, this comparison uses AUC's matching period rather than that later one. Fiscal calendars differ across companies, so two matching fiscal years can still end months apart, on either side of each other: past 183 days no winner is called, and past 400 days the column reads "n.m." throughout and nothing is compared across it. Source: SEC EDGAR XBRL (10-K). "n/a" = not disclosed under mapped tags; never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.